Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02697175
Other study ID # COLPO-2
Secondary ID
Status Completed
Phase N/A
First received February 28, 2016
Last updated March 22, 2017
Start date August 2016
Est. completion date March 2017

Study information

Verified date March 2017
Source Zydolab - Institute of Cytology and Immune Cytochemistry
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the effect of live video-colposcopy on women´s anxiety.


Recruitment information / eligibility

Status Completed
Enrollment 275
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- women referred for colposcopy due to cervical abnormalities

- We included women if they attended colposcopy for the first time

Exclusion Criteria:

- pregnant women

- presence of a language barrier

- known anxiety disorder or depression

- history of conization or other treatments

- known oncological disorder

- inadequate colposcopy

Study Design


Intervention

Device:
Live Video-Colposcopy
The colposcopy will be shown in real time on a flat screen
Other:
No Live Video-Colposcopy
The TV will be shut off during colposcopy

Locations

Country Name City State
Germany Zydolab - Institute of Cytology and Immune Cytochemistry Dortmund NRW
Germany Department of Obstetrics and Gynecology of the Ruhr University Bochum Herne NRW

Sponsors (1)

Lead Sponsor Collaborator
Zydolab - Institute of Cytology and Immune Cytochemistry

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Anxiety score after colposcopy Each women completes the state anxiety questionnaire (state-trait anxiety inventory [STAI]) 10 minutes after colposcopy. 10 minutes
Secondary Change in anxiety scores Each women completes the state anxiety questionnaire (state-trait anxiety inventory [STAI]) before and 10 minutes after colposcopy. The difference in scores before and after colposcopy will be measured. 10 minutes
Secondary Pain during examination women scores their pain level using a horizontal 100-mm visual analogue scale (VAS) ranging from 0 (,no pain') to 10 (,worst imaginable pain'). 10 minutes
Secondary Pain after examination women scores their pain level using a horizontal 100-mm visual analogue scale (VAS) ranging from 0 (,no pain') to 10 (,worst imaginable pain'). 10 minutes
Secondary general unpleasantness during examination women scores their feeeling during colposcopy using a horizontal 100-mm visual analogue scale (VAS) ranging from 0 ("not at all unpleasant") to 10 ("extremely unpleasant"). 10 minutes
Secondary Anxiety during examination women scores their anxiety during colposcopy using a horizontal 100-mm visual analogue scale (VAS) ranging from 0 ("no anxiety at all") to 10 ("worst imaginable anxiety") 10 minutes
Secondary Satisfaction concerning the medical consultation women scores their satisfaction using a horizontal 100-mm visual analogue scale (VAS) ranging from 0 ("maximally unsatisfied") to 10 ("maximally satisfied"). 10 minutes
Secondary Overall Satisfaction women scores their satisfaction using a horizontal 100-mm visual analogue scale (VAS) ranging from 0 ("maximally unsatisfied") to 10 ("maximally satisfied"). 10 minutes
See also
  Status Clinical Trial Phase
Completed NCT01505920 - Lidocaine Spray Compared With Submucosal Injection During LEEP: a Randomized Controlled Trial Phase 3
Completed NCT01014026 - Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention Phase 3
Completed NCT00377845 - Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear. Phase 0
Completed NCT02910388 - LLETZ Under Direct Colposcopic Vision N/A
Completed NCT00596258 - A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL) Phase 2
Completed NCT03763565 - Effectiveness of HPV Vaccine in Thai Adult Women
Completed NCT04415840 - Lugol's Solution in Addition to Acetic Acid During Colposcopy
Recruiting NCT04783805 - Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
Completed NCT04326049 - LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy N/A
Completed NCT02486471 - Hemostatic Procedure After Biopsy of the Cervix N/A
Completed NCT02515162 - Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization N/A
Completed NCT01405768 - Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs) Phase 2
Completed NCT00264732 - A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix Phase 2/Phase 3
Completed NCT03296566 - The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams N/A
Completed NCT02346227 - Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix Phase 3
Completed NCT02330471 - Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial Phase 3
Completed NCT01035580 - Trial on Safety and Pharmacokinetics of Intravaginal Curcumin Phase 1
Completed NCT01639820 - Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts N/A
Completed NCT00285207 - Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix Phase 2
Recruiting NCT05225493 - HIV Indicator Diseases in Hospital and Primary Care